Skip to main content

12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus

OSI-774 (Erlotinib, Tarceva) in Elderly Patients

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about OSI-774 (Erlotinib, Tarceva) in Elderly Patients

Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • …
  • Next page Next
  • Last page Last
Subscribe to